Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 938-347-3 | CAS number: 28068-91-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29 February - 6 June 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed according to EU method and in compliance with Good Laboratory Practice.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Reaction mass of (2R,4R)-4-(2,3-dimethylbutan-2-yl)-2-methylcyclohexanone and (2S,4S)-4-(2,3-dimethylbutan-2-yl)-2-methylcyclohexanone
- EC Number:
- 938-347-3
- Cas Number:
- 28068-91-9
- Molecular formula:
- C13H24O
- IUPAC Name:
- Reaction mass of (2R,4R)-4-(2,3-dimethylbutan-2-yl)-2-methylcyclohexanone and (2S,4S)-4-(2,3-dimethylbutan-2-yl)-2-methylcyclohexanone
- Details on test material:
- - Name of test material (as cited in study report): Iriswood
- Substance type: pure active substance
- Physical state: undercooled liquid
1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- The animals were female (CBA/J@Rj) strain mice from Elevage Janvier, Le Genest-Saint-Isle, France. 8 weeks old animals, nulliparous and nonpregnant, were selected having body weights in the range of 21.1-23.8 g.
A controlled environment was maintained in the room with optimal conditions of approximately 15/h air changes, a temperature of 22±3ºC, a relative humidity of 30-70% and a 12 hour artificial fluorescent light/12 hour dark cycle per day (light cycle 7.00-19.00h).
The animals were individually housed in suspended solid floor polypropylene cages furnished with softwood woodflakes.
Drinking water (tap) and food were supplied freely.
After an acclimatisation period of 5 days, animals were randomly selected and marked on the tail.
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Three dose groups of four animals per group were treated for three consecutive days with the test item. The concentrations of the dose groups were 100% (undiluted), 50% (v/v), 25% (v/v) and 0% (negative control).
- No. of animals per dose:
- 4 mice per dose group.
- Details on study design:
- RANGE FINDING TESTS:
A preliminary screening test was performed treating one mouse daily by application of 25 μL of the test item at 100% to the dorsal surface of each ear for three consecutive days. The preliminary test was a screening by daily clinical observation, body weigth evolution measured on Day 1 (prior to dosing) and Day 6, ear thickness measurement on Day 1, 3 and 6, the weight of the lymph nodes and the cell count.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
Criteria used to consider a positive response: If the EC1.4 for any of the treated groups ≤100%, the test item is classified as a sensitiser. EC1.4 is the theoretical concentration resulting in a SI value of 1.4.
TREATMENT PREPARATION AND ADMINISTRATION:
25 µl of the test compound (and negative control) was daily applied to the entire dorsal surface of each ear of each mouse using the tip of a micro pipette for three consecutive days. On day 6, the mice were killed with an intraperitoneal injection of sodium pentobarbital. The draining Auricular lymph node were excised and a single cell suspension was prepared by pooling the lymph node cells of four mice through mechanical tissue disaggregation in 4ml of PBS containing 0.5% BSA into a well of a multi-well 6.
10µl of the cell suspension was diluted in physiological saline solution (NaCl 0.9%). The lymphocytes were counted using a Beckman Coulter Z2 cell counter. The lower and upper selected sizes were 5µm and 15µm resp.
The weight of the animals were recorded prior to exposure to the test compound and on day 6 prior to the intraperitoneal injection. The thickness of the right ear of the animals were measured using a micrometer prior to exposure on day 1, prior to the third exposure on day 3 and after the intraperitoneal injection. Punch biopsies of 8mm in diameter of the apical area of both ears were prepared and weighed on day 6 in order to assess the irritation potential. Any irritation reaction (erythema and oedema) was recorded in parallel and any other observation (dryness, presence of residual test item…) was noted. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The EC1.4 is determined by linear interpolation of the points in the stimulation index dose-response curve immediately above and below the 1.4 threshold.
Results and discussion
- Positive control results:
- A study was performed to assess the sensitivity of the strain mouse with the known sensitiser (positive control) α-hexylcinnamaldehyde (95% pure, CAS 101-86-0). Three groups, each of four animals were treated with 50µl (25µl/ear) at concentrations of 5%, 10% and 25% as a solution in acetone/olive oil (4:1 v/v). A negative control group was included. The EC1.4 value of the positive control was 8.73%.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 2.86
- Test group / Remarks:
- 25% test substance
- Key result
- Parameter:
- SI
- Value:
- 2.61
- Test group / Remarks:
- 50% test substance
- Key result
- Parameter:
- SI
- Value:
- 3.21
- Test group / Remarks:
- 100% test substance
Any other information on results incl. tables
Preliminary test
No mortality and no significant clinical abnormalities or increase in ear thickness was noted in the animal treated at 100%. The body weight on day 1 and 6 were 19.3 and 20.4 g resp. Ear weight on day 6 was 30.5 mg. The weight of the lymph nodes was 9.4 mg and the cell count 10.73·106/ml. The test item is not considered as excessively irritant at the three concentrations. The concentration of 100% has therefore been choosen as the highest concentration for the main test.
Main test
No mortality and no signs of systematic toxicity were noted in test and control animals.
On day 6, a slight dryness to dryness was noted on the treatment site of all animals treated at 50% (4/4) and 100% (4/4).
Body weight evolution of the test animals between day 1-6 were comparable to the control group.
The EC1.4 can not be determined in this study since no interpolation is possible.
No significant increase in ear thickness was noted in animals treated at 25% and 50% (see Table II). Increase in ear thickness (+17.6%) and in ear weight (+47.1%) were noted on day 6 in animals dosed at 100%. Therefore, the test item must be considered as excessively irritant at this concentration.
Table I Cell count, stimulation index and calculation of EC1.4.
Group | concentration | Cell count (x10^6 cells/ml) |
Stimulation Index |
Result | EC1.4 |
1 | 0% | 20.33 | n.a. | n.a. | n.a |
2 | 25% | 58.13 | 2.86 | Positive | n.a. |
3 | 50% | 53.14 | 2.61 | Positive | |
4 | 100% | 65.25 | 3.21 | Positive |
n.a.: not applicable
Table II Ear thickness & weight increases and the assessement of excessive local irritation.
Group | concentration | Ear thickness increase D6/D1 (%) |
Biopsy ear weight Increase (%) |
Excessiveirritation |
1 | 0% | 8.7 | n.a. | no |
2 | 25% | 4.1 | 3.1 | no |
3 | 50% | 3.7 | 9.0 | no |
4 | 100% | 17.6 | 47.1 | yes |
n.a.: not applicable
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The stimulation index is in excess of 1.4 at 25%, 50% and 100% and therefore test substance should be regarded as a skin sensitiser.
- Executive summary:
The skin sensitisation potential of the test substance Iriswood was assessed according to OECD method 429, in the CBA/J strain mouse following topical application to the dorsal ear surface.
Three groups of four animals were treated for three consecutive days (day 1,2 and 3)with 50µl (25µ per ear) with the test compound in acetone/olive oil (4:1 v/v) at concentrations (v/v) of 100% (undiluted), 50%, 25% and 0% (negative control).
On day 6, the proliferation of the lymphocytes in the draining Auricular lymph nodes was determined by cell counting.
No mortality and no signs of systematic toxicity were found in all the animals at all concentrations. A slight dryness to dryness was noted on the treatment site of all animals treated at 50% and 100% on day 6. No significant thickness in ear thickness and ear weight were observed at 25% and 50%, but increased ear thickness and ear weight were noted on day 6 in animals dosed at 100%. The test substance was therefore considered as excessively irritant at 100%.
The stimulation index (SI) calculated by pooled approach was 2.86, 2.61 and 3.21 for the treated groups with test compound concentrations of 25%, 50% and 100%. The EC1.4 could not be determined by linear interpolation. Since the SI>1.4 at concentrations of 25%, 50% and 100%, the test substance is classified as a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.